Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

Martine Hoogendoorn,1 Isaac Corro Ramos,1 Michael Baldwin,2 Laura Luciani,3 Cecile Fabron,4 Bruno Detournay,4 Maureen PMH Rutten-van Mölken1,5 1institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, the Netherlands; 2Boehringer Ingelheim GmbH, Ingelhei...

Full description

Bibliographic Details
Main Authors: Hoogendoorn M, Corro Ramos I, Baldwin M, Luciani L, Fabron C, Detournay B, Rutten-van Mölken MPMH
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:International Journal of COPD
Subjects:
COPD
tiotropium
olodaterol
exacerbations
modeling
QALYs
costs
Online Access:https://www.dovepress.com/long-term-cost-effectiveness-of-the-fixed-dose-combination-of-tiotropi-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/long-term-cost-effectiveness-of-the-fixed-dose-combination-of-tiotropi-peer-reviewed-article-COPD

Similar Items